151 Investments in 86 Companies
28 IPOs & 22 Acquisitions
Cambridge, Massachusetts
Funds Raised:
Health Care, Biotechnology
MPM Capital caters to the healthcare sector with seed, early, and later stage venture, and private equity investments.

Investor Details


Unique to MPM is an internal team of industry experts that has been specifically assembled not only to enable MPM to assess opportunities but to participate in the value creation and value enhancing acitivites once MPM is an investor. They believe that there senior team is the broadest and deepest team in healthcare venture capital, comprised of talented individuals with impressive investing and finance pedigrees, as well as persons who possess specific functional and operating expertise. MPM executives have and will continue to take interim operating positions in portfolio companies. They can "drop in" expertises in chemistry or biology, intellectual property, licensing and business development, clinical trial design and execution, and commercial operations. Whether we are helping build a company, filling in short-term management gaps, or working alongside management to prepare for key value-creating events, they do whatever it takes to help there companies succeed.

Acquisitions (1)

Jun 27, 2001Unknown
DateInvested InRoundPartner(s)
Sep, 2016€40M / Series A (Lead)
Aug, 2016$10M / Series C and
Jul, 2016$57M / Series A (Lead)
Jun, 2016$45M / Series B
Apr, 2016€2M / Series A (Lead)
Apr, 2016undisclosed amount / Series A
Mar, 2016$43M / Series B
Jan, 2016$40M / Series C
Jan, 2016$27M / Series A
Dec, 2015$40M / Series C
Aug, 2015$80M / Series C
Aug, 2015$40M / Series A
Jul, 2015$6.5M / Series A (Lead)
Jul, 2015$115M / Series E
May, 2015undisclosed amount / Seed
Apr, 2015$35M / Series B
Mar, 2015$44M / Series A (Lead)
Mar, 2015$20M / Venture (Lead)
Feb, 2015$70M / Series E, , and
Oct, 2014$24M / Series A
Jul, 2014$32M / Series B (Lead)
Jul, 2014$45M / Series D
Jun, 2014$22M / Series A
May, 2014$45M / Series D
Apr, 2014$20M / Series B (Lead)
Nov, 2013$40M / Series E
Oct, 2013$32M / Series A (Lead)
Sep, 2013$30M / Private Equity (Lead)
Aug, 2013$26.6M / Series B
Jul, 2013$3M / Seed
Apr, 2013$43M / Private Equity
Mar, 2013$8M / Series B
Mar, 2013$48M / Series C
Jan, 2013$12M / Series C
Dec, 2012$57.95M / Series D
Nov, 2012$8M / Series B
Sep, 2012$23M / Series A (Lead)
Sep, 2012$16M / Series A (Lead)
Jul, 2012$38.5M / Series D (Lead)
Jun, 2012$25M / Series B

Current Team (24)


Funds (12)

May 13, 2015MPM BioVentures 2014 LP$350.66M
Aug 20, 2009MPM BioVentures V$173.32M
Feb 15, 2007MPM Bio IV NVS Strategic Fund$101.01M
Apr 27, 2010MPM Bio V NVS Strategic Fund$43.74M
Feb 21, 2012MPM SunStates Fund$20.18M
May 1, 2006MPM BioVentures IV Strategic Fund$10.61M
Jun 3, 2014MPM Bio 2014 NVS Strategic Fund$50.51M
Feb 1, 2007MPM BioVentures IV$440.48M
Mar 15, 2002MPM BioVentures III$949.49M
Unknown Date$550M HealthCare Fund$550M
May 18, 2004MPM BioVentures Strategic Fund$33.65M
May 3, 2016The UBS Oncology Impact Fund$471M

Offices/Locations (2)

  • San Francisco Office

    601 Gateway Boulevard

    Suite 350

    San Francisco, California 94080

    United States

  • HQ

    450 Kendall Street

    Cambridge, Massachusetts 02142

    United States

Past Team (35)


Add Competitors

Add Memberships

Add Images

Add Videos